Genital Herpes - Pipeline Review, H2 2011 by GlobalMarketsDirect

VIEWS: 3 PAGES: 49

Genital Herpes - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Genital Herpes - Pipeline Review, H2 2011', provides an overview of the Genital Herpes therapeutic pipeline. This report provides information on the therapeutic development for Genital Herpes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Genital Herpes. 'Genital Herpes - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Genital Herpes.
- A review of the Genital Herpes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Genital Herpes pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Genital Herpes.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain c

More Info
									Genital Herpes – Pipeline Review, H2 2011




                     Genital Herpes - Pipeline Review, H2 2011
                                                                                          Reference Code: GMDHC1353IDB

                                                                                          Publication Date: September 2011




Genital Herpes – Pipeline Review, H2 2011                                                                     GMDHC1353IDB / Pub September 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                                 Page(1)
Genital Herpes – Pipeline Review, H2 2011



Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        4
List of Figures                                                                                                       5
Introduction                                                                                                          6
     Global Markets Direct Report Coverage                                                                            6
Genital Herpes Overview                                                                                               7
Therapeutics Development                                                                                              8
     An Overview of Pipeline Products for Genital Herpes                                                              8
Genital Herpes Therapeutics under Development by Companies                                                           10
Late Stage Products                                                                                                  12
     Comparative Analysis                                                                                            12
Mid Clinical Stage Products                                                                                          13
     Comparative Analysis                                                                                            13
Early Clinical Stage Products                                                                                        14
     Comparative Analysis                                                                                            14
Pre-Clinical Stage Products                                                                                          15
     Comparative Analysis                                                                                            15
Genital Herpes Therapeutics - Products under Development by Companies                                                16
Companies Involved in Genital Herpes Therapeutics Development                                                        17
     Vical Incorporated                                                                                              17
     Amgen Inc.                                                                                                      17
     Antigenics, Inc.                                                                                                18
     Flamel Technologies S.A.                                                                                        18
     Starpharma Holdings Limited                                                                                     19
     Clavis Pharma ASA                                                                                               19
     Quigley Pharma, Inc.                                                                                            20
     AiCuris GmbH & Co. KG                                                                                           20
     EMS S.A.                                                                                                        21
Genital Herpes - Therapeutics Assessment                                                                             22
     Assessment by Monotherapy Products                                                                              22
     Assessment by Route of Administration                                                                           23
     Assessment by Molecule Type                                                                                     25
Drug Profiles                                                                                                        27
     ImmunoVEX HSV2 - Drug Profile                                                                                   27
          Product Description                                                                                        27
          Mechanism of Action                                                                                        27
          R&D Progress                                                                                               27
     HSV-2 Vaccine - Drug Profile                                                                                    28
          Product Description                                                                                        28
          Mechanism of Action                                                                                        28
          R&D Progress                                                                                               28
     CP-4010 - Drug Profile                                                                                          30
          Product Description                                                                                        30
          Mechanism of Action                                                                                        30
          R&D Progress                                                                                               30
     HerpV - Drug Profile                                                                                            31
          Product Description                                                                                        31


Genital Herpes – Pipeline Review, H2 2011                                                 GMDHC1353IDB / Pub September 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                              Page(2)
Genital Herpes – Pipeline Review, H2 2011


          Mechanism of Action                                                                                                         31
          R&D Progress                                                                                                                31
     QR-446 - Drug Profile                                                                                                            32
          Product Description                                                                                                         32
          Mechanism of Action                                                                                                         32
          R&D Progress                                                                                                                32
     AIC316 - Drug Profile                                                                                                            33
          Product Description                                                                                                         33
          Mechanism of Action                                                                                                         33
          R&D Progress                                                                                                                33
     VivaGel - Drug Profile                                                                                                           34
          Product Description                                                                                                         34
          Mechanism of Action                                                                                                         34
          R&D Progress                                                                                                                34
     Genvir - Drug Profile                                                                                                            35
          Product Description                                                                                                         35
          Mechanism of Action                                                                                                         35
          R&D Progress                                                                                                                35
     Famciclovir - Drug Profile                                                                                                       37
          Product Description                                                                                                         37
          Mechanism of Action                                                                                                         37
          R&D Progress                                                                                                                37
Genital Herpes Therapeutics – Drug Profile Updates                                                                                    38
Genital Herpes Therapeutics - Discontinued Products                                                                                   41
     Genital Herpes - Featured News                                                                                                   42
          Sep 05, 2011: AiCuris To Present Results Of Resistance Analysis From Phase II Clinical Trial Of AIC316                      42
          Jul 18, 2011: AiCuris's AIC316 Shows Efficacy In Phase II Results                                                           42
          Jun 28, 2011: Vical Provides Herpes Simplex Vaccine Updates At BIO International Convention                                 43
          Jun 27, 2011: Agenus’s Herpes Study Results Presented At BIO International Convention Show Robust Immune Response           43
          Dec 08, 2010: AiCuris Completes Phase II Genital Herpes Trial With AIC316                                                   44
          Nov 05, 2010: AiCuris To Present Preclinical And Phase I Data Of Anti-HSV Drug AIC316 At Antivirals Congress                44
          Jul 27, 2010: Antigenics Announces Positive Phase I Trial Results Of AG-707 For Treatment Of Genital Herpes                 45
          Mar 04, 2010: BioVex Commences Dosing In Phase I Study Of ImmunoVEX Live Attenuated Genital Herpes Vaccine                  46
          Feb 23, 2010: Genocea Biosciences Licenses Extensive Herpes Simplex Virus Patent Estate From The University Of Washington   46
          Feb 23, 2010: Genocea Biosciences Licenses Extensive Herpes Simplex Virus Patent Estate From The University Of Washington   47
Appendix                                                                                                                              48
     Methodology                                                                                                                      48
          Coverage                                                                                                                    48
          Secondary Research                                                                                                          48
          Primary Research                                                                                                            48
          Expert Panel Validation                                                                                                     49
     Contact Us                                                                                                                       49
     Disclaimer                                                                                                                       49




Genital Herpes – Pipeline Review, H2 2011                                                            GMDHC1353IDB / Pub September 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                               Page(3)
Genital Herpes – Pipeline Review, H2 2011




Lis t o f Ta b le s
Number of Products Under Development for Genital Herpes, H2 2011                                                      8

Products under Development for Genital Herpes – Comparative Analysis, H2 2011                                         9

Number of Products under Development by Companies, H2 2011                                                           11

Comparative Analysis by Late Stage Development, H2 2011                                                              12

Comparative Analysis by Mid Clinical Stage Development, H2 2011                                                      13

Comparative Analysis by Early Clinical Stage Development, H
								
To top